MXPA01011311A - Composiciones anticonceptivas que contienen antiprogestina y progestina. - Google Patents

Composiciones anticonceptivas que contienen antiprogestina y progestina.

Info

Publication number
MXPA01011311A
MXPA01011311A MXPA01011311A MXPA01011311A MXPA01011311A MX PA01011311 A MXPA01011311 A MX PA01011311A MX PA01011311 A MXPA01011311 A MX PA01011311A MX PA01011311 A MXPA01011311 A MX PA01011311A MX PA01011311 A MXPA01011311 A MX PA01011311A
Authority
MX
Mexico
Prior art keywords
substituted
alkyl
aminoalkyl
alkoxy
alkynyl
Prior art date
Application number
MXPA01011311A
Other languages
English (en)
Inventor
Todd K Jones
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/552,350 external-priority patent/US6444668B1/en
Application filed by American Home Prod filed Critical American Home Prod
Publication of MXPA01011311A publication Critical patent/MXPA01011311A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
MXPA01011311A 1999-05-04 2000-05-01 Composiciones anticonceptivas que contienen antiprogestina y progestina. MXPA01011311A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30471299A 1999-05-04 1999-05-04
US09/552,350 US6444668B1 (en) 1999-05-04 2000-04-19 Combination regimens using progesterone receptor modulators
PCT/US2000/011643 WO2000066164A1 (en) 1999-05-04 2000-05-01 Contraceptive compositions containing antiprogestinic and progestinic

Publications (1)

Publication Number Publication Date
MXPA01011311A true MXPA01011311A (es) 2003-07-14

Family

ID=26974177

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA01011311A MXPA01011311A (es) 1999-05-04 2000-05-01 Composiciones anticonceptivas que contienen antiprogestina y progestina.

Country Status (14)

Country Link
EP (1) EP1173210B1 (es)
JP (1) JP2002543155A (es)
CN (1) CN1179753C (es)
AT (1) ATE275973T1 (es)
AU (1) AU4682000A (es)
CA (1) CA2372773A1 (es)
DE (1) DE60013798T2 (es)
DK (1) DK1173210T3 (es)
ES (1) ES2226833T3 (es)
HK (1) HK1043736B (es)
MX (1) MXPA01011311A (es)
PT (1) PT1173210E (es)
SI (1) SI1173210T1 (es)
WO (1) WO2000066164A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP1699A (en) 2001-03-21 2006-12-26 Warner Lambert Co New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
EP1558618A1 (en) 2002-10-11 2005-08-03 Ligand Pharmaceuticals, Inc. 5-(1 ,1 -CYCLOALKYL/ALKENYL)METHYLIDENE 1,2-DIHYDRO- 5H /-CHROMENO[3,4-f ] QUINOLINES AS SELECTIVE PROGESTERONE RECEPTOR MODULATOR COMPOUNDS
AU2003258050A1 (en) 2002-10-11 2004-05-04 Ligand Pharmaceuticals Incorporated 5-cycloalkenyl 5h-chromeno(3,4-f)quinoline derivatives as selective progesterone receptor modulator compounds
AR047398A1 (es) * 2003-11-24 2006-01-18 Wyeth Corp Acoplamiento cruzado carbono- carbono catalizado por metales de transicion sobre soportes solidos
AU2005237520B2 (en) * 2004-04-27 2012-01-19 Wyeth Purification of progesterone receptor modulators
WO2006023158A2 (en) 2004-07-14 2006-03-02 Ligand Pharmaceuticals, Inc. Mineralocorticoid receptor modulator compounds and methods, and pharmaceutical compositions containing these compounds
WO2006010142A2 (en) * 2004-07-14 2006-01-26 Ligand Pharmaceuticals, Inc. Mineralocorticoid receptor modulator compounds, processes for their preparation, and their use
EP1774970A1 (de) * 2005-10-13 2007-04-18 Bayer Schering Pharma AG Verfahren zur Herstellung eines einphasigen pharmazeutischen Präparates zur Therapie der dysfunktionellen uterinen Blutung, enthaltend Ethinylestradiol und Dienogest
DE102008022221A1 (de) * 2008-05-06 2009-11-12 Universität des Saarlandes Inhibitoren der humanen Aldosteronsynthase CYP11B2

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3733478A1 (de) * 1987-10-01 1989-04-13 Schering Ag Antigestagen- und antioestrogenwirksame verbindungen zur geburtseinleitung und zum schwangerschaftsabbruch sowie zur behandlung gynaekologischer stoerungen und hormonabhaengiger tumore
DE4330234A1 (de) * 1993-09-02 1995-03-09 Schering Ag Verwendung von Gestagenen und kompetitiven Progesteronantagonisten zur Herstellung von Arzneimitteln für die weibliche Fertilitätskontrolle sowie Mittel enthaltend ein Gestagen und einen kompetitiven Progesteronantagonisten
DE4344463A1 (de) * 1993-12-22 1995-06-29 Schering Ag Kombinationsprodukt zur Kontrazeption
PT792152E (pt) * 1994-11-22 2004-07-30 Balance Pharmaceuticals Inc Metodos de contracepcao
US5521166A (en) * 1994-12-19 1996-05-28 Ortho Pharmaceitical Corporation Antiprogestin cyclophasic hormonal regimen
NZ332894A (en) * 1996-06-25 1999-05-28 Akzo Nobel Nv A regimen containing progestogen and/or estrogen with two or more anti-progestogen dosage units

Also Published As

Publication number Publication date
AU4682000A (en) 2000-11-17
EP1173210A1 (en) 2002-01-23
HK1043736A1 (en) 2002-09-27
DK1173210T3 (da) 2005-01-24
ATE275973T1 (de) 2004-10-15
DE60013798D1 (de) 2004-10-21
EP1173210B1 (en) 2004-09-15
CN1179753C (zh) 2004-12-15
HK1043736B (zh) 2005-04-01
PT1173210E (pt) 2005-01-31
WO2000066164A8 (en) 2001-05-03
CN1349415A (zh) 2002-05-15
DE60013798T2 (de) 2005-09-29
SI1173210T1 (en) 2005-02-28
WO2000066164A1 (en) 2000-11-09
CA2372773A1 (en) 2000-11-09
ES2226833T3 (es) 2005-04-01
JP2002543155A (ja) 2002-12-17

Similar Documents

Publication Publication Date Title
WO2000066165A8 (en) Contraceptive compositions containing quinazolinone and benzoxazine derivatives
DK1175398T3 (da) Indolinderivater som progesteronantagonister
UA72917C2 (en) Cyclic carbamates derivatives, pharmaceutical composition containing said derivatives of cyclic carbamates and active ingredients as modulators of the progesterone receptor
CY1105688T1 (el) Κυανοπυρρολες ως αγωνιστες υποδοχεων προγεστερονης
MX9504349A (es) Derivados de aroilpiperidina.
WO2000066103A3 (en) Contraceptive compositions containing cyclic urea and amide derivatives
HUP0400250A2 (hu) 5-HT6 és/vagy 5-HT7 szerotonin receptorok ligandumaként alkalmazott 5-halogén-triptamin-származékok, előállításuk és alkalmazásuk gyógyszerkészítmények előállítására
WO2000066225A8 (en) Contraceptive compositions containing cyclic carbamates and amide derivatives
HK1043736A1 (en) Contraceptive compositions containing antiprogestinic and progestinic.
NO973243L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av gynekologiske sykdommer
BR9811769A (pt) Tetraidro gama-carbolinas
HUP0203332A2 (hu) Ciklotiokarbamát-származékok, progeszteron receptor modulátorokként való alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
ATE460412T1 (de) Trisubstituierte thiophene als progesteronreceptor-modulatoren
TWI265032B (en) Pharmaceutically useful kits comprising progesterone receptor modulators
TR200002831A2 (tr) Kinolin-4-İl türevleri I
EA200101180A1 (ru) Производные тио-оксиндола
SI1809602T1 (sl) Indolni derivati, uporabni kot modulatorji progesteronskega receptorja
BR0010213A (pt) Derivados de ciclocarbamato como moduladores de receptor de progesterona
AR024549A1 (es) Uso de moduladores de progesterona del receptor de progesterona y kit farmaceutica para regimenes ciclicos
AR023854A1 (es) Uso de derivados de indolina y equipo farmaceutico para regimenes ciclicos
RU97113497A (ru) Применение 3,4-дифенилхроманов для получения фармацевтической композиции для лечения или профилактики гинекологических заболеваний
GEP20043221B (en) Cyclothiocarbamate Derivatives as Progesterone Receptor Modulators, Pharmaceutical Composition Containing Them and Use Thereof for Treatment Progesterone-Related Maladies.

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: WYETH

HC Change of company name or juridical status

Owner name: WYETH

FA Abandonment or withdrawal